Article -> Article Details

Carisoprodol is a pharmaceutical compound used in products intended for the relief of discomfort associated with acute, painful musculoskeletal conditions. For pharmaceutical companies sourcing key raw materials, Carisoprodol intermediate manufacturers in India can play an important role in maintaining a dependable supply chain for API production. Understanding the chemical identity, function, and quality requirements of carisoprodol intermediates is therefore valuable for manufacturers, procurement teams, and pharmaceutical businesses.

What Are Carisoprodol Intermediates?

Pharmaceutical intermediates are chemical substances formed or used during the synthesis of an active pharmaceutical ingredient (API). They occupy an important position between starting materials and the final API, helping manufacturers achieve the required molecular structure through controlled chemical transformations.

Carisoprodol has the molecular formula C12H24N2O4 and a molecular weight of approximately 260.33 g/mol. PubChem identifies carisoprodol as CID 2576 and lists multiple chemical names and identifiers associated with the compound.

One important compound associated with the carisoprodol manufacturing pathway is 2-methyl-2-propyl-1,3-propanediol, also known as 2-methyl-2-propylpropane-1,3-diol. PubChem identifies this compound with CAS No. 78-26-2, molecular formula C7H16O2, and molecular weight of approximately 132.20 g/mol. It is also listed as a carisoprodol impurity in chemical databases.

Chemical Identity of Key Intermediates

The chemical identity of an intermediate is important because it determines its role in a particular synthesis route. 2-Methyl-2-propyl-1,3-propanediol contains two hydroxyl groups that can participate in subsequent chemical transformations. Its molecular structure provides the carbon framework incorporated into carisoprodol.

PubChem records the SMILES representation of this compound as CCCC(C)(CO)CO and confirms its CAS number as 78-26-2. The compound is also associated with several alternative names, including 2,2-dimethylolpentane and 2-methyl-2-propylpropane-1,3-diol.

For pharmaceutical procurement, these identifiers can be useful when preparing specifications, reviewing supplier documentation, and distinguishing an intermediate from the finished API or related substances.

Role of Intermediates in Carisoprodol Manufacturing

Intermediates are important because they provide the structural building blocks required to produce the final pharmaceutical compound. Publicly available chemical references describe a manufacturing route in which 2-methyl-2-propyl-1,3-propanediol is involved in the preparation of carisoprodol.

At a high level, the process involves functional-group transformations that ultimately produce the carbamate functionalities present in carisoprodol. This illustrates why the quality and consistency of an intermediate can influence subsequent manufacturing stages.

For manufacturers, controlling intermediate quality helps reduce variability during downstream processing. Parameters such as identity, purity, related substances, residual solvents, moisture, and other specification requirements may be evaluated according to the applicable manufacturing and quality-control framework.

Pharmaceutical Applications

The principal pharmaceutical relevance of these intermediates comes from their role in producing carisoprodol API. Carisoprodol is classified as a centrally acting skeletal muscle relaxant and is used in pharmaceutical products for short-term relief associated with acute, painful musculoskeletal conditions.

The intermediate itself should not be confused with the finished medicinal product. An intermediate is a manufacturing-stage chemical, whereas the API is the active substance incorporated into a pharmaceutical formulation.

This distinction is particularly important for buyers because specifications, regulatory documentation, analytical requirements, and intended uses can differ significantly between an intermediate and the finished API.

Why Quality Matters When Sourcing Intermediates

For Carisoprodol intermediate manufacturers in India, consistent quality is a key consideration when supplying pharmaceutical companies. Intermediate quality can affect downstream processing, impurity profiles, yield, and the ability to meet established API specifications.

A qualified supplier may provide documentation such as a Certificate of Analysis (COA), product specifications, batch information, safety documentation, and other technical records appropriate to the transaction and applicable regulations.

Buyers may also evaluate manufacturing capabilities, analytical infrastructure, batch-to-batch consistency, production capacity, quality systems, traceability, and export experience when assessing an intermediate supplier.

Choosing a Carisoprodol Intermediate Supplier

Pharmaceutical companies looking for Carisoprodol intermediate manufacturers in India should consider more than price and availability. A structured supplier assessment can help establish whether a manufacturer is capable of consistently meeting the buyer's technical requirements.

Important considerations may include:

• Confirmed chemical identity and applicable CAS number

• Defined product specifications and acceptance criteria

• Consistent batch quality

• Appropriate analytical testing capabilities

• Manufacturing capacity and scalability

• Documentation and traceability

• Quality-management practices

• Packaging and storage controls

• Experience with pharmaceutical customers and international supply

The precise requirements will depend on the intermediate, intended application, applicable regulations, and the buyer's internal quality standards.

India as a Source for Pharmaceutical Intermediates

India has an established pharmaceutical manufacturing sector and supplies APIs, intermediates, and other pharmaceutical materials to domestic and international markets. For companies evaluating Carisoprodol intermediate manufacturers in India, the country's manufacturing ecosystem can provide access to chemical-processing capabilities, analytical services, and pharmaceutical supply-chain infrastructure.

However, supplier qualification remains essential. Buyers should independently verify manufacturing capabilities, product specifications, quality documentation, and regulatory suitability before entering into a commercial supply arrangement.

Conclusion

Carisoprodol intermediates are an important part of the chemical supply chain supporting the production of carisoprodol API. Compounds such as 2-methyl-2-propyl-1,3-propanediol have a defined chemical identity and documented relationship to carisoprodol chemistry.

For pharmaceutical companies, understanding intermediate chemistry and quality requirements can support more informed sourcing and supplier-qualification decisions. A manufacturer capable of providing consistent quality, reliable documentation, appropriate analytical support, and dependable supply can become an important part of a pharmaceutical API supply chain.

Other Recommendations: CAS no 137862-53-4